Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucocorticoid receptor ligands for the treatment of metabolic disorders

Glucocorticoid receptor ligands for the treatment of metabolic disorders

US Patent 7521439 · Granted Apr 21, 2009

Estimated economic value: $36,342,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for selective proteolysis of glucocorticoid receptors2024
Inhibitors of phospholipid synthesis and methods of use2023
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2023
Process for manufacturing a cyclic urea adduct of an ethyleneamine compound2022
Methods of treating Parkinson's disease2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2021
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoqu2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2021
Protein tyrosine phosphatase inhibitors and methods of use thereof2021
Protein tyrosine phosphatase inhibitors and methods of use thereof2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020